Saturday, October 3, 2026

GBP/EUR Is 1% Down In The Last 21 Sessions

ViaNews Editorial Team

November 14, 2023

GBP/EUR Is 1% Down In The Last 21 Sessions

(VIANEWS) - GBP/EUR (GBPEUR) has been up by 1.92% for the last 21 sessions. At 18:11 EST on Tuesday, 14 November, GBP/EUR (GBPEUR) is $1.15.

GBP/EUR's yearly highs and lows, it's 3.179% up from its 52-week low and 2.387% down from its 52-week high.

Volatility

GBP/EUR's last week, last month's, and last quarter's current intraday variation average was a negative 0.17%, a negative 0.04%, and a positive 0.19%, respectively.

GBP/EUR's highest amplitude of average volatility was 0.17% (last week), 0.18% (last month), and 0.19% (last quarter), respectively.

Forex Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, GBP/EUR's Forex is considered to be overbought (>=80).

News about

  • According to FXStreet on Tuesday, 14 November, "Eren Sengezer, European Session Lead Analyst at FXStreet, offers a brief technical outlook for EUR/USD and explains:", "If the pair climbs above this level and starts using it as support, it could be seen as a convincing sign that EUR/USD is in an uptrend. "
  • Eur/usd price analysis: consolidates below the 1.0700 mark, eyes on eurozone GDP data. According to FXStreet on Monday, 13 November, " From the technical perspective, EUR/USD holds above the 50- and 100-hour Exponential Moving Averages (EMAs) on the four-hour chart, supporting the buyers for the time being. ", " The immediate resistance level for EUR/USD is seen at the upper boundary of the Bollinger Band at 1.0718. "
  • Eur/usd holds below 1.0700, investors await US cpi, eurozone GDP data. According to FXStreet on Monday, 13 November, "The EUR/USD pair kicks off the week in a positive mood during the early Asian trading hours on Monday. "
  • Eur/usd: weekly forecast 12th November - 18th November - 12 November 2023. According to DailyForex on Sunday, 12 November, "However, if the EUR/USD can see early buying power and the 1.06900 quickly established a run higher towards the 1.0700 would certainly be in the cards. ", "If these support levels can prove they are not vulnerable, speculative influences in the EUR/USD may believe this is evidence that the reversal lower from the 1.07260 area on Thursday to fresh lows on Friday may prove to be solid target area for reversals upwards."

More news about GBP/EUR (GBPEUR).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,329 source documents archived
Query this data → isubstrate.com